Company intelligence / Profile preview

RE.DOCTOR

United States/Canadare.doctor ↗

Ownership: Private
Development stage: Other

Overview

RE.DOCTOR offers a commercial digital health platform that uses photoplethysmography (PPG) signals collected from smartphones and wearable devices to scan and monitor vital signs. The solution analyzes data to support triage but does not diagnose or treat disease.

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Device manufacturersMedical device software developersTelehealth providersRemote patient monitoring providers

Beyond the preview

Go deeper on RE.DOCTOR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RE.DOCTOR.

Explore the full profile